411 related articles for article (PubMed ID: 27362314)
1. Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection.
Crespo E; Roedder S; Sigdel T; Hsieh SC; Luque S; Cruzado JM; Tran TQ; Grinyó JM; Sarwal MM; Bestard O
Transplantation; 2017 Jun; 101(6):1400-1409. PubMed ID: 27362314
[TBL] [Abstract][Full Text] [Related]
2. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
[TBL] [Abstract][Full Text] [Related]
3. Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation.
Blydt-Hansen TD; Gibson IW; Gao A; Dufault B; Ho J
Transplantation; 2015 Apr; 99(4):797-804. PubMed ID: 25222013
[TBL] [Abstract][Full Text] [Related]
4. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
[TBL] [Abstract][Full Text] [Related]
5. The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.
Roedder S; Sigdel T; Salomonis N; Hsieh S; Dai H; Bestard O; Metes D; Zeevi A; Gritsch A; Cheeseman J; Macedo C; Peddy R; Medeiros M; Vincenti F; Asher N; Salvatierra O; Shapiro R; Kirk A; Reed EF; Sarwal MM
PLoS Med; 2014 Nov; 11(11):e1001759. PubMed ID: 25386950
[TBL] [Abstract][Full Text] [Related]
6. Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients.
Park S; Guo K; Heilman RL; Poggio ED; Taber DJ; Marsh CL; Kurian SM; Kleiboeker S; Weems J; Holman J; Zhao L; Sinha R; Brietigam S; Rebello C; Abecassis MM; Friedewald JJ
Clin J Am Soc Nephrol; 2021 Oct; 16(10):1539-1551. PubMed ID: 34620649
[TBL] [Abstract][Full Text] [Related]
7. Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.
Rabant M; Amrouche L; Lebreton X; Aulagnon F; Benon A; Sauvaget V; Bonifay R; Morin L; Scemla A; Delville M; Martinez F; Timsit MO; Duong Van Huyen JP; Legendre C; Terzi F; Anglicheau D
J Am Soc Nephrol; 2015 Nov; 26(11):2840-51. PubMed ID: 25948873
[TBL] [Abstract][Full Text] [Related]
8. B-cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients.
Pongpirul W; Chancharoenthana W; Pongpirul K; Leelahavanichkul A; Kittikowit W; Jutivorakool K; Nonthasoot B; Avihingsanon Y; Eiam-Ong S; Praditpornsilpa K; Townamchai N
Nephrology (Carlton); 2018 Feb; 23(2):169-174. PubMed ID: 27888573
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
Yazdani S; Callemeyn J; Gazut S; Lerut E; de Loor H; Wevers M; Heylen L; Saison C; Koenig A; Thaunat O; Thorrez L; Kuypers D; Sprangers B; Noël LH; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
Kidney Int; 2019 Jan; 95(1):188-198. PubMed ID: 30396694
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Early Clinical and Subclinical T Cell-mediated Rejection After Kidney Transplantation.
Hoffman W; Mehta R; Jorgensen DR; Sood P; Randhawa P; Wu CM; Puttarajappa C; Shah NA; Tevar AD; Hariharan S
Transplantation; 2019 Jul; 103(7):1457-1467. PubMed ID: 30747837
[TBL] [Abstract][Full Text] [Related]
11. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of kSORT, a blood-based mRNA assay for noninvasive detection of rejection after kidney transplantation: A retrospective multicenter cohort study.
Van Loon E; Giral M; Anglicheau D; Lerut E; Dubois V; Rabeyrin M; Brouard S; Roedder S; Spigarelli MG; Rabant M; Bogaerts K; Naesens M; Thaunat O
Am J Transplant; 2021 Feb; 21(2):740-750. PubMed ID: 32627407
[TBL] [Abstract][Full Text] [Related]
13. Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation.
Lúcia M; Luque S; Crespo E; Melilli E; Cruzado JM; Martorell J; Jarque M; Gil-Vernet S; Manonelles A; Grinyó JM; Bestard O
Kidney Int; 2015 Oct; 88(4):874-87. PubMed ID: 26176829
[TBL] [Abstract][Full Text] [Related]
14. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
[TBL] [Abstract][Full Text] [Related]
15. Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection.
Tsuji T; Yanai M; Itami H; Ishii Y; Akimoto M; Fukuzawa N; Harada H; Fukasawa Y
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():26-30. PubMed ID: 26031582
[TBL] [Abstract][Full Text] [Related]
16. Long-term kidney allograft survival in patients with transplant glomerulitis.
Nabokow A; Dobronravov VA; Khrabrova M; Gröne HJ; Gröne E; Hallensleben M; Kieneke D; Weithofer P; Smirnov AV; Kliem V
Transplantation; 2015 Feb; 99(2):331-9. PubMed ID: 25594551
[TBL] [Abstract][Full Text] [Related]
17. Sequential monitoring of TIM-3 gene expression in peripheral blood for diagnostic and prognostic evaluation of acute rejection in renal graft recipients.
Luo Y; Shi B; Qian Y; Bai H; Chang J
Transplant Proc; 2011 Dec; 43(10):3669-74. PubMed ID: 22172823
[TBL] [Abstract][Full Text] [Related]
18. Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells.
Shiu KY; McLaughlin L; Rebollo-Mesa I; Zhao J; Burton H; Douthwaite H; Wilkinson H; Semik V; Dodd PC; Brookes P; Lechler RI; Hernandez-Fuentes MP; Kemper C; Dorling A
Kidney Int; 2017 Feb; 91(2):477-492. PubMed ID: 27988211
[TBL] [Abstract][Full Text] [Related]
19. Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
Gandolfini I; Crespo E; Baweja M; Jarque M; Donadei C; Luque S; Montero N; Allesina A; Perin L; Maggiore U; Cravedi P; Bestard O
PLoS One; 2018; 13(7):e0200696. PubMed ID: 30059561
[TBL] [Abstract][Full Text] [Related]
20. CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation.
Raschzok N; Reutzel-Selke A; Schmuck RB; Morgul MH; Gauger U; Prabowo KA; Tannus LM; Leder A; Struecker B; Boas-Knoop S; Bartels M; Jonas S; Lojewski C; Puhl G; Seehofer D; Bahra M; Pascher A; Pratschke J; Sauer IM
Liver Transpl; 2015 Sep; 21(9):1195-207. PubMed ID: 25950774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
